Global Sulfonylureas for Type 2 Diabetes Market Research Report 2026(Status and Outlook)

May 2026 | 200 pages | ID: GDF37E477FDAEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sulfonylureas for Type 2 Diabetes competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.In 2024, global Sulfonylureas for Type 2 Diabetes production reached approximately 4336.42 M Units, with an average global market price of around 5.84 USD per Unit. The global prevalence of type 2 diabetes continues to rise, with an expanding number of high-risk groups such as the middle-aged and elderly, and obese individuals. Some hypoglycemic drugs have limited efficacy in controlling blood sugar or significant adverse reactions. Sulfonylureas, however, balance the core needs of ""achieving therapeutic goals"" and ""safe medication"" with their potent blood sugar-lowering effects and optimized safety profile. They are particularly suitable for high-risk groups such as the middle-aged and elderly, and those with underlying medical conditions, eliminating clinical concerns about ""unstable blood sugar control"" or ""excessive risk."" As a classic oral hypoglycemic agent for the treatment of type 2 diabetes, sulfonylureas precisely address the core pain points in clinical treatment, and their market potential continues to expand against the backdrop of a continuously rising global demand for diabetes prevention and control.Sulfonylureas are a class of oral medications used primarily to treat Type 2 Diabetes Mellitus. They are among the oldest and most widely used anti-diabetic drugs, known for their high efficacy and relatively low cost.Sulfonylureas for Type 2 Diabetes are mainly divided into Glibenclamide, Glipizide, Gliclazide, Glizidone, and Glimepiride, which have advantages such as strong hypoglycemic effect, milder side effects, and more convenient dosing frequency.The upstream raw materials for Sulfonylureas for Type 2 Diabetes mainly include active ingredients such as glibenclamide, glipizide, gliclazide, glimepiride, and glimepiride. Typical suppliers include AGC Pharma Chemicals, ICROM, Gedeon Richter, and Dr. Reddy's Laboratories. Downstream applications are mainly in hospitals and pharmacies. The single-line production capacity of Sulfonylureas for Type 2 Diabetes varies significantly depending on the dosage form and production scale, with annual production capacity typically ranging from 50 million to 150 million tablets, and gross profit margins usually between 30% and 50%.

The global Sulfonylureas for Type 2 Diabetes market size was estimated at USD 25325.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Sulfonylureas for Type 2 Diabetes market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Sulfonylureas for Type 2 Diabetes market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Sulfonylureas for Type 2 Diabetes market.

Global Sulfonylureas for Type 2 Diabetes Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

  • Sanofi
  • Pfizer
  • Teva
  • AdvaCare Pharma
  • Krka
  • Lupin Healthcare
  • Viatris (Mylan)
  • Apotex Corporation
  • Hoechst Canada
  • Hikma Pharmaceuticals
  • Servier Laboratories
  • Aurobindo Pharma
  • Zydus Cadila Healthcare
  • Accord Healthcare
  • Taj Pharma
  • Boehringer Ingelheim
  • Qingdao Double Whale Pharmaceutical
  • CHANGZHOU SUNLIGHT PHARMACEUTICAL
  • Zhejiang Shapuaisi Pharmaceutical
  • DISHA PHARMACEUTICAL GROUP
  • Shandong Lukang Pharmaceutical
  • Beijing Jingfeng pharmaceutical
  • Suzhou Zhonghua Pharmaceutical Industry
  • Shanghai SINE United Pharmaceuticals
  • Zhuhai United Pharmaceutical
  • Changzhou Siyao Pharmaceuticals
  • Shijiazhuang Yiling Pharmaceutical
  • Jiangsu Vanguard Pharmaceutical
  • China Resources Shuanghe Pharmaceutical
  • TIPR PHARMACEUTICAL

Market Segmentation (by Type)

  • Glibenclamide
  • Glipizide
  • Gliclazide
  • Glizidone
  • Glimepiride

Market Segmentation (by Application)

  • Hospital
  • Pharmacy

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Sulfonylureas for Type 2 Diabetes Market

Overview of the regional outlook of the Sulfonylureas for Type 2 Diabetes Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Sulfonylureas for Type 2 Diabetes Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Sulfonylureas for Type 2 Diabetes, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Sulfonylureas for Type 2 Diabetes
1.2 Key Market Segments
  1.2.1 Sulfonylureas for Type 2 Diabetes Segment by Type
  1.2.2 Sulfonylureas for Type 2 Diabetes Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SULFONYLUREAS FOR TYPE 2 DIABETES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Sulfonylureas for Type 2 Diabetes Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Sulfonylureas for Type 2 Diabetes Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SULFONYLUREAS FOR TYPE 2 DIABETES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Sulfonylureas for Type 2 Diabetes Product Life Cycle
3.3 Global Sulfonylureas for Type 2 Diabetes Sales by Manufacturers (2020-2025)
3.4 Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Manufacturers (2020-2025)
3.5 Sulfonylureas for Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Sulfonylureas for Type 2 Diabetes Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Sulfonylureas for Type 2 Diabetes Market Competitive Situation and Trends
  3.8.1 Sulfonylureas for Type 2 Diabetes Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Sulfonylureas for Type 2 Diabetes Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 SULFONYLUREAS FOR TYPE 2 DIABETES INDUSTRY CHAIN ANALYSIS

4.1 Sulfonylureas for Type 2 Diabetes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SULFONYLUREAS FOR TYPE 2 DIABETES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Sulfonylureas for Type 2 Diabetes Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Sulfonylureas for Type 2 Diabetes Market
5.7 ESG Ratings of Leading Companies

6 SULFONYLUREAS FOR TYPE 2 DIABETES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Type (2020-2025)
6.3 Global Sulfonylureas for Type 2 Diabetes Market Size by Type (2020-2025)
6.4 Global Sulfonylureas for Type 2 Diabetes Price by Type (2020-2025)

7 SULFONYLUREAS FOR TYPE 2 DIABETES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Sulfonylureas for Type 2 Diabetes Market Sales by Application (2020-2025)
7.3 Global Sulfonylureas for Type 2 Diabetes Market Size (M USD) by Application (2020-2025)
7.4 Global Sulfonylureas for Type 2 Diabetes Sales Growth Rate by Application (2020-2025)

8 SULFONYLUREAS FOR TYPE 2 DIABETES MARKET SALES BY REGION

8.1 Global Sulfonylureas for Type 2 Diabetes Sales by Region
  8.1.1 Global Sulfonylureas for Type 2 Diabetes Sales by Region
  8.1.2 Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Region
8.2 Global Sulfonylureas for Type 2 Diabetes Market Size by Region
  8.2.1 Global Sulfonylureas for Type 2 Diabetes Market Size by Region
  8.2.2 Global Sulfonylureas for Type 2 Diabetes Market Size by Region
8.3 North America
  8.3.1 North America Sulfonylureas for Type 2 Diabetes Sales by Country
  8.3.2 North America Sulfonylureas for Type 2 Diabetes Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Sulfonylureas for Type 2 Diabetes Sales by Country
  8.4.2 Europe Sulfonylureas for Type 2 Diabetes Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Sulfonylureas for Type 2 Diabetes Sales by Region
  8.5.2 Asia Pacific Sulfonylureas for Type 2 Diabetes Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Sulfonylureas for Type 2 Diabetes Sales by Country
  8.6.2 South America Sulfonylureas for Type 2 Diabetes Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales by Region
  8.7.2 Middle East and Africa Sulfonylureas for Type 2 Diabetes Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 SULFONYLUREAS FOR TYPE 2 DIABETES MARKET PRODUCTION BY REGION

9.1 Global Production of Sulfonylureas for Type 2 Diabetes by Region(2020-2025)
9.2 Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Region (2020-2025)
9.3 Global Sulfonylureas for Type 2 Diabetes Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Sulfonylureas for Type 2 Diabetes Production
  9.4.1 North America Sulfonylureas for Type 2 Diabetes Production Growth Rate (2020-2025)
  9.4.2 North America Sulfonylureas for Type 2 Diabetes Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Sulfonylureas for Type 2 Diabetes Production
  9.5.1 Europe Sulfonylureas for Type 2 Diabetes Production Growth Rate (2020-2025)
  9.5.2 Europe Sulfonylureas for Type 2 Diabetes Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Sulfonylureas for Type 2 Diabetes Production (2020-2025)
  9.6.1 Japan Sulfonylureas for Type 2 Diabetes Production Growth Rate (2020-2025)
  9.6.2 Japan Sulfonylureas for Type 2 Diabetes Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Sulfonylureas for Type 2 Diabetes Production (2020-2025)
  9.7.1 China Sulfonylureas for Type 2 Diabetes Production Growth Rate (2020-2025)
  9.7.2 China Sulfonylureas for Type 2 Diabetes Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Sanofi
  10.1.1 Sanofi Basic Information
  10.1.2 Sanofi Sulfonylureas for Type 2 Diabetes Product Overview
  10.1.3 Sanofi Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.1.4 Sanofi Business Overview
  10.1.5 Sanofi SWOT Analysis
  10.1.6 Sanofi Recent Developments
10.2 Pfizer
  10.2.1 Pfizer Basic Information
  10.2.2 Pfizer Sulfonylureas for Type 2 Diabetes Product Overview
  10.2.3 Pfizer Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.2.4 Pfizer Business Overview
  10.2.5 Pfizer SWOT Analysis
  10.2.6 Pfizer Recent Developments
10.3 Teva
  10.3.1 Teva Basic Information
  10.3.2 Teva Sulfonylureas for Type 2 Diabetes Product Overview
  10.3.3 Teva Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.3.4 Teva Business Overview
  10.3.5 Teva SWOT Analysis
  10.3.6 Teva Recent Developments
10.4 AdvaCare Pharma
  10.4.1 AdvaCare Pharma Basic Information
  10.4.2 AdvaCare Pharma Sulfonylureas for Type 2 Diabetes Product Overview
  10.4.3 AdvaCare Pharma Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.4.4 AdvaCare Pharma Business Overview
  10.4.5 AdvaCare Pharma Recent Developments
10.5 Krka
  10.5.1 Krka Basic Information
  10.5.2 Krka Sulfonylureas for Type 2 Diabetes Product Overview
  10.5.3 Krka Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.5.4 Krka Business Overview
  10.5.5 Krka Recent Developments
10.6 Lupin Healthcare
  10.6.1 Lupin Healthcare Basic Information
  10.6.2 Lupin Healthcare Sulfonylureas for Type 2 Diabetes Product Overview
  10.6.3 Lupin Healthcare Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.6.4 Lupin Healthcare Business Overview
  10.6.5 Lupin Healthcare Recent Developments
10.7 Viatris (Mylan)
  10.7.1 Viatris (Mylan) Basic Information
  10.7.2 Viatris (Mylan) Sulfonylureas for Type 2 Diabetes Product Overview
  10.7.3 Viatris (Mylan) Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.7.4 Viatris (Mylan) Business Overview
  10.7.5 Viatris (Mylan) Recent Developments
10.8 Apotex Corporation
  10.8.1 Apotex Corporation Basic Information
  10.8.2 Apotex Corporation Sulfonylureas for Type 2 Diabetes Product Overview
  10.8.3 Apotex Corporation Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.8.4 Apotex Corporation Business Overview
  10.8.5 Apotex Corporation Recent Developments
10.9 Hoechst Canada
  10.9.1 Hoechst Canada Basic Information
  10.9.2 Hoechst Canada Sulfonylureas for Type 2 Diabetes Product Overview
  10.9.3 Hoechst Canada Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.9.4 Hoechst Canada Business Overview
  10.9.5 Hoechst Canada Recent Developments
10.10 Hikma Pharmaceuticals
  10.10.1 Hikma Pharmaceuticals Basic Information
  10.10.2 Hikma Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Overview
  10.10.3 Hikma Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.10.4 Hikma Pharmaceuticals Business Overview
  10.10.5 Hikma Pharmaceuticals Recent Developments
10.11 Servier Laboratories
  10.11.1 Servier Laboratories Basic Information
  10.11.2 Servier Laboratories Sulfonylureas for Type 2 Diabetes Product Overview
  10.11.3 Servier Laboratories Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.11.4 Servier Laboratories Business Overview
  10.11.5 Servier Laboratories Recent Developments
10.12 Aurobindo Pharma
  10.12.1 Aurobindo Pharma Basic Information
  10.12.2 Aurobindo Pharma Sulfonylureas for Type 2 Diabetes Product Overview
  10.12.3 Aurobindo Pharma Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.12.4 Aurobindo Pharma Business Overview
  10.12.5 Aurobindo Pharma Recent Developments
10.13 Zydus Cadila Healthcare
  10.13.1 Zydus Cadila Healthcare Basic Information
  10.13.2 Zydus Cadila Healthcare Sulfonylureas for Type 2 Diabetes Product Overview
  10.13.3 Zydus Cadila Healthcare Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.13.4 Zydus Cadila Healthcare Business Overview
  10.13.5 Zydus Cadila Healthcare Recent Developments
10.14 Accord Healthcare
  10.14.1 Accord Healthcare Basic Information
  10.14.2 Accord Healthcare Sulfonylureas for Type 2 Diabetes Product Overview
  10.14.3 Accord Healthcare Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.14.4 Accord Healthcare Business Overview
  10.14.5 Accord Healthcare Recent Developments
10.15 Taj Pharma
  10.15.1 Taj Pharma Basic Information
  10.15.2 Taj Pharma Sulfonylureas for Type 2 Diabetes Product Overview
  10.15.3 Taj Pharma Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.15.4 Taj Pharma Business Overview
  10.15.5 Taj Pharma Recent Developments
10.16 Boehringer Ingelheim
  10.16.1 Boehringer Ingelheim Basic Information
  10.16.2 Boehringer Ingelheim Sulfonylureas for Type 2 Diabetes Product Overview
  10.16.3 Boehringer Ingelheim Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.16.4 Boehringer Ingelheim Business Overview
  10.16.5 Boehringer Ingelheim Recent Developments
10.17 Qingdao Double Whale Pharmaceutical
  10.17.1 Qingdao Double Whale Pharmaceutical Basic Information
  10.17.2 Qingdao Double Whale Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
  10.17.3 Qingdao Double Whale Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.17.4 Qingdao Double Whale Pharmaceutical Business Overview
  10.17.5 Qingdao Double Whale Pharmaceutical Recent Developments
10.18 CHANGZHOU SUNLIGHT PHARMACEUTICAL
  10.18.1 CHANGZHOU SUNLIGHT PHARMACEUTICAL Basic Information
  10.18.2 CHANGZHOU SUNLIGHT PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product Overview
  10.18.3 CHANGZHOU SUNLIGHT PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.18.4 CHANGZHOU SUNLIGHT PHARMACEUTICAL Business Overview
  10.18.5 CHANGZHOU SUNLIGHT PHARMACEUTICAL Recent Developments
10.19 Zhejiang Shapuaisi Pharmaceutical
  10.19.1 Zhejiang Shapuaisi Pharmaceutical Basic Information
  10.19.2 Zhejiang Shapuaisi Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
  10.19.3 Zhejiang Shapuaisi Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.19.4 Zhejiang Shapuaisi Pharmaceutical Business Overview
  10.19.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments
10.20 DISHA PHARMACEUTICAL GROUP
  10.20.1 DISHA PHARMACEUTICAL GROUP Basic Information
  10.20.2 DISHA PHARMACEUTICAL GROUP Sulfonylureas for Type 2 Diabetes Product Overview
  10.20.3 DISHA PHARMACEUTICAL GROUP Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.20.4 DISHA PHARMACEUTICAL GROUP Business Overview
  10.20.5 DISHA PHARMACEUTICAL GROUP Recent Developments
10.21 Shandong Lukang Pharmaceutical
  10.21.1 Shandong Lukang Pharmaceutical Basic Information
  10.21.2 Shandong Lukang Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
  10.21.3 Shandong Lukang Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.21.4 Shandong Lukang Pharmaceutical Business Overview
  10.21.5 Shandong Lukang Pharmaceutical Recent Developments
10.22 Beijing Jingfeng pharmaceutical
  10.22.1 Beijing Jingfeng pharmaceutical Basic Information
  10.22.2 Beijing Jingfeng pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
  10.22.3 Beijing Jingfeng pharmaceutical Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.22.4 Beijing Jingfeng pharmaceutical Business Overview
  10.22.5 Beijing Jingfeng pharmaceutical Recent Developments
10.23 Suzhou Zhonghua Pharmaceutical Industry
  10.23.1 Suzhou Zhonghua Pharmaceutical Industry Basic Information
  10.23.2 Suzhou Zhonghua Pharmaceutical Industry Sulfonylureas for Type 2 Diabetes Product Overview
  10.23.3 Suzhou Zhonghua Pharmaceutical Industry Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.23.4 Suzhou Zhonghua Pharmaceutical Industry Business Overview
  10.23.5 Suzhou Zhonghua Pharmaceutical Industry Recent Developments
10.24 Shanghai SINE United Pharmaceuticals
  10.24.1 Shanghai SINE United Pharmaceuticals Basic Information
  10.24.2 Shanghai SINE United Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Overview
  10.24.3 Shanghai SINE United Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.24.4 Shanghai SINE United Pharmaceuticals Business Overview
  10.24.5 Shanghai SINE United Pharmaceuticals Recent Developments
10.25 Zhuhai United Pharmaceutical
  10.25.1 Zhuhai United Pharmaceutical Basic Information
  10.25.2 Zhuhai United Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
  10.25.3 Zhuhai United Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.25.4 Zhuhai United Pharmaceutical Business Overview
  10.25.5 Zhuhai United Pharmaceutical Recent Developments
10.26 Changzhou Siyao Pharmaceuticals
  10.26.1 Changzhou Siyao Pharmaceuticals Basic Information
  10.26.2 Changzhou Siyao Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Overview
  10.26.3 Changzhou Siyao Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.26.4 Changzhou Siyao Pharmaceuticals Business Overview
  10.26.5 Changzhou Siyao Pharmaceuticals Recent Developments
10.27 Shijiazhuang Yiling Pharmaceutical
  10.27.1 Shijiazhuang Yiling Pharmaceutical Basic Information
  10.27.2 Shijiazhuang Yiling Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
  10.27.3 Shijiazhuang Yiling Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.27.4 Shijiazhuang Yiling Pharmaceutical Business Overview
  10.27.5 Shijiazhuang Yiling Pharmaceutical Recent Developments
10.28 Jiangsu Vanguard Pharmaceutical
  10.28.1 Jiangsu Vanguard Pharmaceutical Basic Information
  10.28.2 Jiangsu Vanguard Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
  10.28.3 Jiangsu Vanguard Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.28.4 Jiangsu Vanguard Pharmaceutical Business Overview
  10.28.5 Jiangsu Vanguard Pharmaceutical Recent Developments
10.29 China Resources Shuanghe Pharmaceutical
  10.29.1 China Resources Shuanghe Pharmaceutical Basic Information
  10.29.2 China Resources Shuanghe Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
  10.29.3 China Resources Shuanghe Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.29.4 China Resources Shuanghe Pharmaceutical Business Overview
  10.29.5 China Resources Shuanghe Pharmaceutical Recent Developments
10.30 TIPR PHARMACEUTICAL
  10.30.1 TIPR PHARMACEUTICAL Basic Information
  10.30.2 TIPR PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product Overview
  10.30.3 TIPR PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product Market Performance
  10.30.4 TIPR PHARMACEUTICAL Business Overview
  10.30.5 TIPR PHARMACEUTICAL Recent Developments

11 SULFONYLUREAS FOR TYPE 2 DIABETES MARKET FORECAST BY REGION

11.1 Global Sulfonylureas for Type 2 Diabetes Market Size Forecast
11.2 Global Sulfonylureas for Type 2 Diabetes Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Sulfonylureas for Type 2 Diabetes Market Size Forecast by Country
  11.2.3 Asia Pacific Sulfonylureas for Type 2 Diabetes Market Size Forecast by Region
  11.2.4 South America Sulfonylureas for Type 2 Diabetes Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Sulfonylureas for Type 2 Diabetes by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Sulfonylureas for Type 2 Diabetes Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Sulfonylureas for Type 2 Diabetes by Type (2026-2035)
  12.1.2 Global Sulfonylureas for Type 2 Diabetes Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Sulfonylureas for Type 2 Diabetes by Type (2026-2035)
12.2 Global Sulfonylureas for Type 2 Diabetes Market Forecast by Application (2026-2035)
  12.2.1 Global Sulfonylureas for Type 2 Diabetes Sales (K MT) Forecast by Application
  12.2.2 Global Sulfonylureas for Type 2 Diabetes Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Sulfonylureas for Type 2 Diabetes Market Size by Type (M USD)
Table 4. Global Sulfonylureas for Type 2 Diabetes Market Size by Application
Table 5. Sulfonylureas for Type 2 Diabetes Market Size Comparison by Region (M USD)
Table 6. Global Sulfonylureas for Type 2 Diabetes Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Sulfonylureas for Type 2 Diabetes Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Sulfonylureas for Type 2 Diabetes Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulfonylureas for Type 2 Diabetes as of 2025)
Table 11. Global Market Sulfonylureas for Type 2 Diabetes Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Sulfonylureas for Type 2 Diabetes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Sulfonylureas for Type 2 Diabetes Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Sulfonylureas for Type 2 Diabetes Sales by Type (K MT)
Table 27. Global Sulfonylureas for Type 2 Diabetes Market Size by Type (M USD)
Table 28. Global Sulfonylureas for Type 2 Diabetes Sales (K MT) by Type (2020-2025)
Table 29. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Type (2020-2025)
Table 30. Global Sulfonylureas for Type 2 Diabetes Market Size (M USD) by Type (2020-2025)
Table 31. Global Sulfonylureas for Type 2 Diabetes Market Share by Type (2020-2025)
Table 32. Global Sulfonylureas for Type 2 Diabetes Price (USD/KG) by Type (2020-2025)
Table 33. Global Sulfonylureas for Type 2 Diabetes Sales (K MT) by Application
Table 34. Global Sulfonylureas for Type 2 Diabetes Market Size by Application
Table 35. Global Sulfonylureas for Type 2 Diabetes Sales by Application (2020-2025) & (K MT)
Table 36. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Application (2020-2025)
Table 37. Global Sulfonylureas for Type 2 Diabetes Market Size by Application (2020-2025) & (M USD)
Table 38. Global Sulfonylureas for Type 2 Diabetes Market Share by Application (2020-2025)
Table 39. Global Sulfonylureas for Type 2 Diabetes Sales Growth Rate by Application (2020-2025)
Table 40. Global Sulfonylureas for Type 2 Diabetes Sales by Region (2020-2025) & (K MT)
Table 41. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Region (2020-2025)
Table 42. Global Sulfonylureas for Type 2 Diabetes Market Size by Region (2020-2025) & (M USD)
Table 43. Global Sulfonylureas for Type 2 Diabetes Market Size by Region (2020-2025)
Table 44. North America Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2025) & (K MT)
Table 45. North America Sulfonylureas for Type 2 Diabetes Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2025) & (K MT)
Table 47. Europe Sulfonylureas for Type 2 Diabetes Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Sulfonylureas for Type 2 Diabetes Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Sulfonylureas for Type 2 Diabetes Market Size by Region (2020-2025) & (M USD)
Table 50. South America Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2025) & (K MT)
Table 51. South America Sulfonylureas for Type 2 Diabetes Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Sulfonylureas for Type 2 Diabetes Market Size by Region (2020-2025) & (M USD)
Table 54. Global Sulfonylureas for Type 2 Diabetes Production (K MT) by Region(2020-2025)
Table 55. Global Sulfonylureas for Type 2 Diabetes Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Region (2020-2025)
Table 57. Global Sulfonylureas for Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Sulfonylureas for Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Sulfonylureas for Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Sulfonylureas for Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Sulfonylureas for Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Sulfonylureas for Type 2 Diabetes Product Overview
Table 64. Sanofi Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Pfizer Basic Information
Table 69. Pfizer Sulfonylureas for Type 2 Diabetes Product Overview
Table 70. Pfizer Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pfizer Business Overview
Table 72. Pfizer SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Teva Basic Information
Table 75. Teva Sulfonylureas for Type 2 Diabetes Product Overview
Table 76. Teva Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Teva Business Overview
Table 78. Teva SWOT Analysis
Table 79. Teva Recent Developments
Table 80. AdvaCare Pharma Basic Information
Table 81. AdvaCare Pharma Sulfonylureas for Type 2 Diabetes Product Overview
Table 82. AdvaCare Pharma Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AdvaCare Pharma Business Overview
Table 84. AdvaCare Pharma Recent Developments
Table 85. Krka Basic Information
Table 86. Krka Sulfonylureas for Type 2 Diabetes Product Overview
Table 87. Krka Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Krka Business Overview
Table 89. Krka Recent Developments
Table 90. Lupin Healthcare Basic Information
Table 91. Lupin Healthcare Sulfonylureas for Type 2 Diabetes Product Overview
Table 92. Lupin Healthcare Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Lupin Healthcare Business Overview
Table 94. Lupin Healthcare Recent Developments
Table 95. Viatris (Mylan) Basic Information
Table 96. Viatris (Mylan) Sulfonylureas for Type 2 Diabetes Product Overview
Table 97. Viatris (Mylan) Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Viatris (Mylan) Business Overview
Table 99. Viatris (Mylan) Recent Developments
Table 100. Apotex Corporation Basic Information
Table 101. Apotex Corporation Sulfonylureas for Type 2 Diabetes Product Overview
Table 102. Apotex Corporation Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Apotex Corporation Business Overview
Table 104. Apotex Corporation Recent Developments
Table 105. Hoechst Canada Basic Information
Table 106. Hoechst Canada Sulfonylureas for Type 2 Diabetes Product Overview
Table 107. Hoechst Canada Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Hoechst Canada Business Overview
Table 109. Hoechst Canada Recent Developments
Table 110. Hikma Pharmaceuticals Basic Information
Table 111. Hikma Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Overview
Table 112. Hikma Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Hikma Pharmaceuticals Business Overview
Table 114. Hikma Pharmaceuticals Recent Developments
Table 115. Servier Laboratories Basic Information
Table 116. Servier Laboratories Sulfonylureas for Type 2 Diabetes Product Overview
Table 117. Servier Laboratories Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Servier Laboratories Business Overview
Table 119. Servier Laboratories Recent Developments
Table 120. Aurobindo Pharma Basic Information
Table 121. Aurobindo Pharma Sulfonylureas for Type 2 Diabetes Product Overview
Table 122. Aurobindo Pharma Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Aurobindo Pharma Business Overview
Table 124. Aurobindo Pharma Recent Developments
Table 125. Zydus Cadila Healthcare Basic Information
Table 126. Zydus Cadila Healthcare Sulfonylureas for Type 2 Diabetes Product Overview
Table 127. Zydus Cadila Healthcare Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Zydus Cadila Healthcare Business Overview
Table 129. Zydus Cadila Healthcare Recent Developments
Table 130. Accord Healthcare Basic Information
Table 131. Accord Healthcare Sulfonylureas for Type 2 Diabetes Product Overview
Table 132. Accord Healthcare Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Accord Healthcare Business Overview
Table 134. Accord Healthcare Recent Developments
Table 135. Taj Pharma Basic Information
Table 136. Taj Pharma Sulfonylureas for Type 2 Diabetes Product Overview
Table 137. Taj Pharma Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Taj Pharma Business Overview
Table 139. Taj Pharma Recent Developments
Table 140. Boehringer Ingelheim Basic Information
Table 141. Boehringer Ingelheim Sulfonylureas for Type 2 Diabetes Product Overview
Table 142. Boehringer Ingelheim Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Boehringer Ingelheim Business Overview
Table 144. Boehringer Ingelheim Recent Developments
Table 145. Qingdao Double Whale Pharmaceutical Basic Information
Table 146. Qingdao Double Whale Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
Table 147. Qingdao Double Whale Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Qingdao Double Whale Pharmaceutical Business Overview
Table 149. Qingdao Double Whale Pharmaceutical Recent Developments
Table 150. CHANGZHOU SUNLIGHT PHARMACEUTICAL Basic Information
Table 151. CHANGZHOU SUNLIGHT PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product Overview
Table 152. CHANGZHOU SUNLIGHT PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. CHANGZHOU SUNLIGHT PHARMACEUTICAL Business Overview
Table 154. CHANGZHOU SUNLIGHT PHARMACEUTICAL Recent Developments
Table 155. Zhejiang Shapuaisi Pharmaceutical Basic Information
Table 156. Zhejiang Shapuaisi Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
Table 157. Zhejiang Shapuaisi Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Zhejiang Shapuaisi Pharmaceutical Business Overview
Table 159. Zhejiang Shapuaisi Pharmaceutical Recent Developments
Table 160. DISHA PHARMACEUTICAL GROUP Basic Information
Table 161. DISHA PHARMACEUTICAL GROUP Sulfonylureas for Type 2 Diabetes Product Overview
Table 162. DISHA PHARMACEUTICAL GROUP Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. DISHA PHARMACEUTICAL GROUP Business Overview
Table 164. DISHA PHARMACEUTICAL GROUP Recent Developments
Table 165. Shandong Lukang Pharmaceutical Basic Information
Table 166. Shandong Lukang Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
Table 167. Shandong Lukang Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Shandong Lukang Pharmaceutical Business Overview
Table 169. Shandong Lukang Pharmaceutical Recent Developments
Table 170. Beijing Jingfeng pharmaceutical Basic Information
Table 171. Beijing Jingfeng pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
Table 172. Beijing Jingfeng pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Beijing Jingfeng pharmaceutical Business Overview
Table 174. Beijing Jingfeng pharmaceutical Recent Developments
Table 175. Suzhou Zhonghua Pharmaceutical Industry Basic Information
Table 176. Suzhou Zhonghua Pharmaceutical Industry Sulfonylureas for Type 2 Diabetes Product Overview
Table 177. Suzhou Zhonghua Pharmaceutical Industry Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Suzhou Zhonghua Pharmaceutical Industry Business Overview
Table 179. Suzhou Zhonghua Pharmaceutical Industry Recent Developments
Table 180. Shanghai SINE United Pharmaceuticals Basic Information
Table 181. Shanghai SINE United Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Overview
Table 182. Shanghai SINE United Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. Shanghai SINE United Pharmaceuticals Business Overview
Table 184. Shanghai SINE United Pharmaceuticals Recent Developments
Table 185. Zhuhai United Pharmaceutical Basic Information
Table 186. Zhuhai United Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
Table 187. Zhuhai United Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Zhuhai United Pharmaceutical Business Overview
Table 189. Zhuhai United Pharmaceutical Recent Developments
Table 190. Changzhou Siyao Pharmaceuticals Basic Information
Table 191. Changzhou Siyao Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Overview
Table 192. Changzhou Siyao Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 193. Changzhou Siyao Pharmaceuticals Business Overview
Table 194. Changzhou Siyao Pharmaceuticals Recent Developments
Table 195. Shijiazhuang Yiling Pharmaceutical Basic Information
Table 196. Shijiazhuang Yiling Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
Table 197. Shijiazhuang Yiling Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 198. Shijiazhuang Yiling Pharmaceutical Business Overview
Table 199. Shijiazhuang Yiling Pharmaceutical Recent Developments
Table 200. Jiangsu Vanguard Pharmaceutical Basic Information
Table 201. Jiangsu Vanguard Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
Table 202. Jiangsu Vanguard Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 203. Jiangsu Vanguard Pharmaceutical Business Overview
Table 204. Jiangsu Vanguard Pharmaceutical Recent Developments
Table 205. China Resources Shuanghe Pharmaceutical Basic Information
Table 206. China Resources Shuanghe Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Overview
Table 207. China Resources Shuanghe Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 208. China Resources Shuanghe Pharmaceutical Business Overview
Table 209. China Resources Shuanghe Pharmaceutical Recent Developments
Table 210. TIPR PHARMACEUTICAL Basic Information
Table 211. TIPR PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product Overview
Table 212. TIPR PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 213. TIPR PHARMACEUTICAL Business Overview
Table 214. TIPR PHARMACEUTICAL Recent Developments
Table 215. Global Sulfonylureas for Type 2 Diabetes Sales Forecast by Region (2026-2035) & (K MT)
Table 216. Global Sulfonylureas for Type 2 Diabetes Market Size Forecast by Region (2026-2035) & (M USD)
Table 217. North America Sulfonylureas for Type 2 Diabetes Sales Forecast by Country (2026-2035) & (K MT)
Table 218. North America Sulfonylureas for Type 2 Diabetes Market Size Forecast by Country (2026-2035) & (M USD)
Table 219. Europe Sulfonylureas for Type 2 Diabetes Sales Forecast by Country (2026-2035) & (K MT)
Table 220. Europe Sulfonylureas for Type 2 Diabetes Market Size Forecast by Country (2026-2035) & (M USD)
Table 221. Asia Pacific Sulfonylureas for Type 2 Diabetes Sales Forecast by Region (2026-2035) & (K MT)
Table 222. Asia Pacific Sulfonylureas for Type 2 Diabetes Market Size Forecast by Region (2026-2035) & (M USD)
Table 223. South America Sulfonylureas for Type 2 Diabetes Sales Forecast by Country (2026-2035) & (K MT)
Table 224. South America Sulfonylureas for Type 2 Diabetes Market Size Forecast by Country (2026-2035) & (M USD)
Table 225. Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales Forecast by Country (2026-2035) & (Units)
Table 226. Middle East and Africa Sulfonylureas for Type 2 Diabetes Market Size Forecast by Country (2026-2035) & (M USD)
Table 227. Global Sulfonylureas for Type 2 Diabetes Sales Forecast by Type (2026-2035) & (K MT)
Table 228. Global Sulfonylureas for Type 2 Diabetes Market Size Forecast by Type (2026-2035) & (M USD)
Table 229. Global Sulfonylureas for Type 2 Diabetes Price Forecast by Type (2026-2035) & (USD/KG)
Table 230. Global Sulfonylureas for Type 2 Diabetes Sales (K MT) Forecast by Application (2026-2035)
Table 231. Global Sulfonylureas for Type 2 Diabetes Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Sulfonylureas for Type 2 Diabetes
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Sulfonylureas for Type 2 Diabetes Market Size (M USD), 2025-2035
Figure 5. Global Sulfonylureas for Type 2 Diabetes Market Size (M USD) (2020-2035)
Figure 6. Global Sulfonylureas for Type 2 Diabetes Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Sulfonylureas for Type 2 Diabetes Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Sulfonylureas for Type 2 Diabetes Product Life Cycle
Figure 13. Sulfonylureas for Type 2 Diabetes Sales Share by Manufacturers in 2025
Figure 14. Global Sulfonylureas for Type 2 Diabetes Revenue Share by Manufacturers in 2025
Figure 15. Sulfonylureas for Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Sulfonylureas for Type 2 Diabetes Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Sulfonylureas for Type 2 Diabetes Revenue in 2025
Figure 18. Industry Chain Map of Sulfonylureas for Type 2 Diabetes
Figure 19. Global Sulfonylureas for Type 2 Diabetes Market PEST Analysis
Figure 20. Global Sulfonylureas for Type 2 Diabetes Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Sulfonylureas for Type 2 Diabetes Market Share by Type
Figure 27. Sales Market Share of Sulfonylureas for Type 2 Diabetes by Type (2020-2025)
Figure 28. Sales Market Share of Sulfonylureas for Type 2 Diabetes by Type in 2025
Figure 29. Market Share of Sulfonylureas for Type 2 Diabetes by Type (2020-2025)
Figure 30. Market Share of Sulfonylureas for Type 2 Diabetes by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Sulfonylureas for Type 2 Diabetes Market Share by Application
Figure 33. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Application (2020-2025)
Figure 34. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Application in 2025
Figure 35. Global Sulfonylureas for Type 2 Diabetes Market Share by Application (2020-2025)
Figure 36. Global Sulfonylureas for Type 2 Diabetes Market Share by Application in 2025
Figure 37. Global Sulfonylureas for Type 2 Diabetes Sales Growth Rate by Application (2020-2025)
Figure 38. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Region (2020-2025)
Figure 39. Global Sulfonylureas for Type 2 Diabetes Market Size by Region (2020-2025)
Figure 40. North America Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Sulfonylureas for Type 2 Diabetes Sales Market Share by Country in 2024
Figure 43. North America Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Sulfonylureas for Type 2 Diabetes Market Size by Country in 2024
Figure 45. U.S. Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Sulfonylureas for Type 2 Diabetes Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Sulfonylureas for Type 2 Diabetes Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Sulfonylureas for Type 2 Diabetes Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Sulfonylureas for Type 2 Diabetes Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Sulfonylureas for Type 2 Diabetes Sales Market Share by Country in 2024
Figure 53. Europe Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Sulfonylureas for Type 2 Diabetes Market Size by Country in 2024
Figure 55. Germany Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Sulfonylureas for Type 2 Diabetes Sales Market Share by Region in 2024
Figure 67. Asia Pacific Sulfonylureas for Type 2 Diabetes Market Size by Region in 2024
Figure 68. China Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (K MT)
Figure 79. South America Sulfonylureas for Type 2 Diabetes Sales Market Share by Country in 2024
Figure 80. South America Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (M USD)
Figure 81. South America Sulfonylureas for Type 2 Diabetes Market Size by Country in 2024
Figure 82. Brazil Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Sulfonylureas for Type 2 Diabetes Market Size by Region in 2024
Figure 92. Saudi Arabia Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Sulfonylureas for Type 2 Diabetes Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Sulfonylureas for Type 2 Diabetes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Sulfonylureas for Type 2 Diabetes Production Market Share by Region (2020-2025)
Figure 103. North America Sulfonylureas for Type 2 Diabetes Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Sulfonylureas for Type 2 Diabetes Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Sulfonylureas for Type 2 Diabetes Production (K MT) Growth Rate (2020-2025)
Figure 106. China Sulfonylureas for Type 2 Diabetes Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Sulfonylureas for Type 2 Diabetes Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Sulfonylureas for Type 2 Diabetes Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Sulfonylureas for Type 2 Diabetes Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Sulfonylureas for Type 2 Diabetes Market Share Forecast by Type (2026-2035)
Figure 111. Global Sulfonylureas for Type 2 Diabetes Sales Forecast by Application (2026-2035)
Figure 112. Global Sulfonylureas for Type 2 Diabetes Market Share Forecast by Application (2026-2035)